Zynx Health Announces Availability of Knowledge Analyzer

LOS ANGELES, July 22, 2014--Zynx Health™, the market leader in providing evidence- and experience-based clinical improvement solutions, has announced the general availability of Knowledge Analyzer™, a scalable solution that helps organizations quickly realize the full value of electronic health record (EHR) systems.

Healthcare organizations typically have limited time to make meaningful adjustments to EHRs as they strive to quickly realize the technology's intended clinical and financial benefits. Unfortunately, without the inclusion of fine-tuned evidence-based content, many organizations fail to efficiently optimize their EHRs. As a result, these organizations may never realize the intended clinical benefits and promised financial savings of their EHR systems. Knowledge Analyzer enables organizations to not only access—but to optimally leverage—clinical decision support, providing an opportunity to use EHRs to improve clinical outcomes, reduce readmissions, enhance financial performance, manage Value-Based Purchasing, and achieve Meaningful Use as well as other mandates.

Mary Horan, MD, CMIO at UW Medicine/Northwest Hospital & Medical Center (a 281-bed hospital in Seattle, Washington), explained, "With Knowledge Analyzer, we have been able to continually analyze and identify the evidence-based content deemed most important to our clinicians. Our team of healthcare professionals undoubtedly wants to provide the most current and evidence-based care. The ability to streamline the order set review process with an intelligent, current, and easy-to-use tool makes the updates and maintenance process of clinical decision support much easier. It also ensures the availability of relevant clinical guidance when we need it most. We can now optimize our EHR with the information that will make a real difference in patient care."

"Knowledge Analyzer helps us to continually enhance our EHR's clinical guidance while also supporting far-reaching quality improvement efforts," Dr. Horan added. "Our physicians and nurses already see the value of the EHR with well-designed CPOE, and they truly embrace the system. Keeping it relevant and current is the challenge once the initial buy-in has occurred, and Zynx Health helps us do that."

With Knowledge Analyzer, healthcare organizations can quickly analyze vast amounts of clinical content against the most current evidence, bringing added transparency to clinical practice. The assessment will instantly pinpoint opportunities essential to decreasing care variation and improving performance in clinician practices, with a focus on the most vital interventions that advance clinical and financial outcomes.

"We are enabling healthcare organizations to provide care guidance at crucial care moments that can truly make a difference. With Knowledge Analyzer, we are not just providing the most current and most relevant content, but are helping organizations analyze how that content can be used in their environment and in their situations to improve patient care," Carol Leighton, vice president of product management at Zynx Health explained. "In essence, we are supporting a 'carpe diem' mentality by showing providers how to get the most out of their information technology sooner, rather than later."

About UW Medicine/Northwest Hospital & Medical Center
Founded in 1960, UW Medicine/Northwest Hospital & Medical Center is a full-service, non-profit hospital located just north of downtown Seattle. With 281 licensed beds, more than 1,900 employees, and all private rooms, UW Medicine/Northwest Hospital & Medical Center offers some of the most innovative, technologically advanced medical care available. Major clinical programs and services include: inpatient, outpatient, and emergency services; primary care; cancer care; cardiac care; neurosciences and a Level 1 stroke center; orthopedics and sports medicine; childbirth services; multiple sclerosis center; hernia center; geropsychiatric center; and education and wellness programs. In 2010, Northwest Hospital joined the UW Medicine health system. For more information about UW Medicine/Northwest Hospital & Medical Center and its programs and services, call 206.364.0500 or visit nwhospital.org.

About Zynx Health
Zynx Health, part of the Hearst Health network, is the pioneer and market leader in evidence- and experience-based clinical improvement solutions that provide the care guidance to enhance quality and decrease variation across an individual's health journey. Thousands of hospital organizations and providers "dare to be better" with Zynx Health's innovative solutions based on rigorous and tested methodologies that improve performance in clinical practice. With Zynx Health, healthcare organizations exceed industry demands for delivering high-quality care at lower costs under value-based reimbursement models. Zynx Health partners with healthcare organizations to continuously and measurably improve care every day, for every patient, every time. To learn more, visit zynxhealth.com or call 855.367.ZYNX.

About Hearst Health
Zynx Health is part of the Hearst Health network, which also includes FDB (First Databank), MCG (formerly Milliman Care Guidelines) and Homecare Homebase. The mission of the Hearst Health network is to help guide the most important care moments by delivering vital information into the hands of everyone who touches a person's health journey. Each year in the U.S., care guidance from the Hearst Health network reaches 76% of discharged patients, 133 million insured individuals, 20 million home health visits, 1.88 billion retail pharmacy prescriptions and 3.26 billion prescription claims. Extensions of the Hearst Health network include Hearst Health Ventures and the Hearst Health Innovation Lab. www.hearsthealth.com

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.